Mobile.outsourcing-pharma.com

Las Vegas, Nevada, and Osaka, Japan, April 28, 2011, – Affymax, Inc. (Nasdaq: AFFY) and Takeda Pharmaceutical Company Limited (TSE:4502, “Takeda”), today announced results of additional analyses from two Phase 3 studies (EMERALD 1 and 2) of the investigational...

There are many investors who believe that the stock market is currently overvalued. To a great extent, they may be correct as there is a lot of excessive valuation to be found in various segments of the market. However, as I believe it is a market of...

PRA Health Sciences Inc. (NASDAQ:PRAH) – Equities research analysts at William Blair increased their FY2016 earnings per share estimates for shares of PRA Health Sciences in a research report issued to clients and investors on Monday. William Blair analyst...

ga('create', 'UA-47275228-1', 'getnews.info'); ga('send', 'pageview'); Home Business Lifestyle Health & Medicine Technology Financial Market U.S. World Home » Business, Health & Medicine, Pharmaceuticals & Biotech, Science, Services...

[Capital Cube] PRA Health Sciences Inc (NASDAQ:PRAH)(TREND ANALYSIS) Share Price Performance Relative to Peers PRAH-US has traded publicly for less than a year. PRAH-US‘s shares have traded publicly for less than a year. Over the last one month, however...